Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2005-06-28 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BRUNOY (91800), Essonne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BELLE PLACE : revenue, balance sheet and financial ratios
PHARMACIE BELLE PLACE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BRUNOY (91800),
this company of category PME
shows in 2025 a net income positive of 597 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BELLE PLACE (SIREN 483097135)
Indicator
2025
2024
2023
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
597 008 €
77 055 €
21 926 €
139 880 €
170 809 €
134 358 €
89 159 €
-8 617 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE BELLE PLACE generates positive net income of 597 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
597 008 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 33%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
33.073%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
65.161%
Solvency indicators evolution PHARMACIE BELLE PLACE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2023
2024
2025
Debt ratio
419.526
308.195
213.572
179.111
135.62
87.2
63.21
33.073
Financial autonomy
16.195
20.12
26.282
31.257
35.723
42.568
49.122
65.161
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
33.072025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-17 pts over 3 years
In 2025, the debt ratio of PHARMACIE BELLE PLACE (33.07) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
65.16%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+23 pts over 3 years
In 2025, the financial autonomy of PHARMACIE BELLE PLACE (65.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 752.55. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
752.549
Liquidity indicators evolution PHARMACIE BELLE PLACE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2023
2024
2025
Liquidity ratio
111.369
102.987
107.232
201.818
180.746
123.979
102.558
752.549
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
752.552025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent+52 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE BELLE PLACE (752.55) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE BELLE PLACE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE BELLE PLACE is estimated at
9 483 543 €
(range 6 435 577€ - 14 880 984€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
6435k€9483k€14880k€
9 483 543 €Range: 6 435 577€ - 14 880 984€
NAF 5 année 2025
Valuation method used
Net Income Multiple
597 008 €
×
15.9x
=9 483 543 €
Range: 6 435 577€ - 14 880 985€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BELLE PLACE with other companies in the same sector:
Frequently asked questions about PHARMACIE BELLE PLACE
What is the revenue of PHARMACIE BELLE PLACE ?
The revenue of PHARMACIE BELLE PLACE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE BELLE PLACE profitable?
Yes, PHARMACIE BELLE PLACE generated a net profit of 597 k€ in 2025.
Where is the headquarters of PHARMACIE BELLE PLACE ?
The headquarters of PHARMACIE BELLE PLACE is located in BRUNOY (91800), in the department Essonne.
Where to find the tax return of PHARMACIE BELLE PLACE ?
The tax return of PHARMACIE BELLE PLACE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BELLE PLACE operate?
PHARMACIE BELLE PLACE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart